gE-specific total IgGBiomarker2 papers study itSee all 2LatestBMC Infectious Diseases·Mar 20Immune response to the recombinant herpes zoster vaccine in people living with HIV over 50 years of age compared to non-HIV age-/gender-matched controls (SHINGR'HIV): a multicenter, international, non-randomized clinical trial study protocolStudy protocolHerpes zosterPaperResearch Square·Feb 20Immune response to the recombinant herpes zoster vaccine in people living with HIV over 50 years of age compared to non-HIV age-/gender-matched controls (SHINGR’HIV): a multicenter, international, non-randomized clinical trial study protocolPreprint: study protocolHerpes zosterPaper
BMC Infectious Diseases·Mar 20Immune response to the recombinant herpes zoster vaccine in people living with HIV over 50 years of age compared to non-HIV age-/gender-matched controls (SHINGR'HIV): a multicenter, international, non-randomized clinical trial study protocolStudy protocolHerpes zosterPaper
Research Square·Feb 20Immune response to the recombinant herpes zoster vaccine in people living with HIV over 50 years of age compared to non-HIV age-/gender-matched controls (SHINGR’HIV): a multicenter, international, non-randomized clinical trial study protocolPreprint: study protocolHerpes zosterPaper